Related Experiment Videos
Epidermolytic hyperkeratosis (bullous ichthyosis)
Journal of the European Academy of Dermatology and Venereology : JEADV
|February 24, 2001
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Treatment of 25 Cases of Psoriasis with Oral Aromatic Retinoid (tigason).
Indian journal of dermatology, venereology and leprology·2017
Treatment of 22 Cases of Selected Non-psoriatic Dermatoses with Oral Aromatic Retinoid (Tigason).
Indian journal of dermatology, venereology and leprology·2017
Ketoconazole Therapy in Pityriasis Versicolor.
Indian journal of dermatology, venereology and leprology·2017
Behcet's Disease (A Study of 23 Cases From Tripoli, Libya).
Indian journal of dermatology, venereology and leprology·2017
Herpes Gestationis in Tripoli (Libya) (clinical Study of Twelve Cases).
Indian journal of dermatology, venereology and leprology·2017
Epidermolysis Bullosa Acquisita (Report of three Cases).
Indian journal of dermatology, venereology and leprology·2017
Dermatological manifestations associated with chemsex.
Journal of the European Academy of Dermatology and Venereology : JEADV·2026
European consensus recommendations for nummular eczema: A modified Delphi study.
Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Cutaneous embryology: Physiological basis and clinical implications.
Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Proteomic analysis in hidradenitis suppurativa reveals systemic inflammation in all disease stages.
Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Addiction in chronic inflammatory skin diseases: A systematic review of prevalence, impact and screening practices.
Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026